Ubs Group Ag Tiziana Life Sciences LTD Put Options Transaction History
Ubs Group Ag
- $527 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding TLSA
# of Institutions
33Shares Held
996KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA246KShares$262,9220.0% of portfolio
-
Morgan Stanley New York, NY111KShares$118,5890.0% of portfolio
-
Hsbc Holdings PLC London, X0105KShares$112,7400.0% of portfolio
-
Zhang Financial LLC96.3KShares$102,9980.01% of portfolio
-
Kovitz Investment Group Partners, LLC79.4KShares$84,9200.0% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $109M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...